There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.
Older teens may have similar risk factors for prescription opioid overdose as adults.
Researchers reported full results of the 5-year GAS trial, the first randomized controlled trial to assess the effects of general anesthesia in infancy on neurodevelopmental outcomes.
The FDA has granted marketing clearance for eNeura’s single-pulse transcranial magnetic stimulation (sTMS) device for use in patients ≥12 years for the acute and prophylactic treatment of migraine.
The effectiveness of only 10 of 43 available pain measurement instruments specific to neonates has been examined in studies deemed of poor to fair quality.
Childhood cancer survivors are at risk for long-term peripheral neuropathy, particularly when treated with cisplatin.
In this retrospective analysis of the Pediatric Health Information System database, investigators obtained data on pediatric hospitalizations for opioid exposure in the US between 2004 and 2015.
Researchers introduce and investigate a new category of headache termed undifferentiated headache in a pediatric population.
A recent study evaluated the prevalence of persistent pain after pediatric ambulatory surgery 1, 3 and 6 months, as well as risk factors for persistent pain.
The Food and Drug Administration is requiring that changes be made to the labeling of prescription cough and cold medicines containing codeine and hydrocodone.
